Avascular Necrosis, Correction of a Functional Deformity, Femoral Fracture, Osteoarthritis, Rheumatoid Arthritis
Conditions
Brief summary
The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.
Interventions
DEVICEEncore Linear™ Hip System
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis, have received the hip system and are willing to participate in the study.
Sponsors
Encore Medical, L.P.
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Have hip joint disease related to one or more of the following * osteoarthritis * rheumatoid arthritis * femoral fracture * correction of a functional deformity * avascular necrosis of the natural femoral head * Skeletal maturity * Patient is likely to be available for evaluation for the duration of the study * Able and willing to sign the informed consent and follow study procedures * Patient is not pregnant * No infection present * No known materials sensitivity * Patient is over 18 years of age
Exclusion criteria
* Skeletal immaturity * Infection or sepsis * Insufficient bone quality that may affect the stability of the implant * Muscular, neurologic or vascular deficiencies which compromise the affected extremity * Alcoholism or other addictions * Prisoners * High levels of physical activity * Patient is pregnant * Loss of ligamentous structures * Materials sensitivity * Patient is under 18 years of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The use and efficacy of the Encore Linear™ Hip System | 2 year |
Countries
United States
Outcome results
None listed